• Increase in the prevalence of Turners’ syndrome and Down’s syndrome among newborn babies drives the market growth
• Surge in the adoption of next-gen non-invasive DNA tests in high-risk pregnancies is likely to fuel profitable prospects in the market

WILMINGTON, Del., Oct. 5, 2022 /PRNewswire/ — The global non-invasive prenatal testing market is prognosticated to reach a value of US$ 8.4 Bn by the end of 2031, notes an analysis by Transparency Market Research (TMR). In addition, the non-invasive prenatal testing market outlook by TMR finds that the market is expected to develop at a CAGR of 14.8% during the forecast period, between 2022 and 2031.

Due to the presence of many well-entrenched players, the competition levels in the market seem to be highly intense. Thus, companies are using different strategies such as collaborations and partnerships in order to stay ahead of the competition. This aside, enterprises are focusing on the development of highly effective testing solutions. Hence, they are investing heavily in R&Ds. Such efforts are prognosticated to fuel the market expansion, states a TMR study that enlightens readers on the emerging trends of non-invasive prenatal testing market.

Get Exclusive PDF Sample Copy of Non-invasive Prenatal Testing Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=374

Enterprises in the non-invasive prenatal testing market are concentrating on the incorporation of advancements and improvements in…